Pages that link to "Q35648656"

The following pages link to Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway (Q35648656):

Displayed 50 items.

• The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes (Q24292337) ‎ (← links)
• Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I (Q24296692) ‎ (← links)
• Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I (Q24300380) ‎ (← links)
• Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter (Q24303830) ‎ (← links)
• ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I (Q24303897) ‎ (← links)
• The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease (Q24306475) ‎ (← links)
• Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells (Q24306543) ‎ (← links)
• Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directions (Q26750131) ‎ (← links)
• The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids (Q27025329) ‎ (← links)
• The unsolved mystery of apoA-I recycling in adipocyte (Q28069220) ‎ (← links)
• The role of signalling in cellular cholesterol homeostasis (Q28294413) ‎ (← links)
• Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization (Q28507990) ‎ (← links)
• ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes (Q28569109) ‎ (← links)
• Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes (Q28589822) ‎ (← links)
• Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I (Q28593742) ‎ (← links)
• ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging. (Q30538189) ‎ (← links)
• Identification of cAMP analogue inducible genes in RAW264 macrophages (Q30928667) ‎ (← links)
• Novel approaches to treating cardiovascular disease: lessons from Tangier disease (Q32066326) ‎ (← links)
• Alpha1-syntrophin modulates turnover of ABCA1. (Q33196798) ‎ (← links)
• Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers (Q33736211) ‎ (← links)
• Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux (Q33999507) ‎ (← links)
• Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body (Q34101270) ‎ (← links)
• Role of membrane organization and membrane domains in endocytic lipid trafficking (Q34156593) ‎ (← links)
• Caveolae and intracellular trafficking of cholesterol (Q34365129) ‎ (← links)
• Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells (Q34431894) ‎ (← links)
• Cellular cholesterol efflux (Q34455387) ‎ (← links)
• Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. (Q34479025) ‎ (← links)
• Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. (Q34583811) ‎ (← links)
• Regulation and mechanisms of macrophage cholesterol efflux (Q34798750) ‎ (← links)
• ABCA1 and nascent HDL biogenesis (Q34958342) ‎ (← links)
• Caveolins and macrophage lipid metabolism (Q35041193) ‎ (← links)
• An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia (Q35152189) ‎ (← links)
• Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment (Q35203793) ‎ (← links)
• Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter (Q35209308) ‎ (← links)
• Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance (Q35456387) ‎ (← links)
• Regulation of ABCA1 functions by signaling pathways (Q35626943) ‎ (← links)
• Effluxed lipids: Tangier Island's latest export (Q36173368) ‎ (← links)
• The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways (Q36331308) ‎ (← links)
• ABCA1, from pathology to membrane function (Q36542860) ‎ (← links)
• The carboxy-terminal region of apoA-I is required for the ABCA1-dependent formation of alpha-HDL but not prebeta-HDL particles in vivo. (Q36859049) ‎ (← links)
• Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL. (Q36927181) ‎ (← links)
• HDL and endothelial protection. (Q36929420) ‎ (← links)
• Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk? (Q37019901) ‎ (← links)
• Regulation of signal transduction by HDL. (Q37076473) ‎ (← links)
• HDL endocytosis and resecretion (Q37226719) ‎ (← links)
• Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease (Q37286296) ‎ (← links)
• An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages. (Q37334574) ‎ (← links)
• Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses (Q37606964) ‎ (← links)
• ABC transporters, atherosclerosis and inflammation (Q37688500) ‎ (← links)
• Cholesteryl ester transfer protein and its inhibition (Q37765864) ‎ (← links)